Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Comment by LuvtoInveston Feb 24, 2021 10:48am
104 Views
Post# 32646503

RE:RE:RE:Glencore

RE:RE:RE:Glencoremiles 44 and MoneyMan123456, let's cool it down a bit.

What Glencore will do or not do is beyond our control. Let us concentrate on facts and the logical actions that the management should take in light of the facts:
  1. At current zinc price, TV is a cash cow.
  2. TV management has no reason to dilute the company further for RP2.0.
  3. Internal cash generation will be sufficient to finance the project if zinc remains at or above current price till June 2022.
  4. If management suspects that zinc price has reached a peak for the forseeable future, they should enter into forward swap @ 1.29 or thereabouts for still unswapped 2021 production and 2022 H1 production to ensure that they don't have to go for further dilution.
If management assures the market that they will not be going for a further dilution to implement RP2.0, market will re-evaluate the stock to around $0.40 in short-term. Glencore may still make an unsolicited bid for the company. However, in that case, Glencare bid will have to be much higher.   
<< Previous
Bullboard Posts
Next >>